So sorry to see Doug leaving. He was the only saving grace in this company. I just hope he takes all of us with him and we can start over with a real product. His experience in hematology will pave the way for our future. Heard GSK is paying huge base salaries. After the Tesaro acquisition, oncology reps there are making mid 170s to low 180s. We can easily bump that number to bring us over.
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
Why are BI oncology reps paid more than the rest of the company?
- Thread starter anonymous
- Start date
-
- Tags
- None
I have had conversations with people that are desperately trying to get back there. Salary is in-line at the 175 range and annual bonus target is 40k. Tough sledding with a new product class in a crowded market. Doug’s VP salary is reported in the low 300’s plus an equity position. Maybe they are playing like a real biotech?
job posting in my state. What's the salary range? 14y, 2 Onc. TIA
took a closer look...several openings. WTH happened in TX? Original question still stands
No person with Onc experience would come here unless they are on a pip, serial hopper or fleeing some other impending doom.
What product/s are the Oncology vacancies posted for? R these backfills or expansions?
R they only hiring experienced Onc reps?
R they only hiring experienced Onc reps?
If you’re too lazy to research the oncology pipeline yourself, you don’t deserve the position.
I was thinking same thing what’s with all the vacancies? Not s good look that’s for sure! Anyone with any Onc experience wouldn’t come to this place.
Similar threads
- anonymous
- Boehringer Ingelheim 2
- anonymous
- Boehringer Ingelheim
- anonymous
- Boehringer Ingelheim
- anonymous
- Boehringer Ingelheim